Jerby-Arnon, Livnat http://orcid.org/0000-0002-4037-386X
Regev, Aviv http://orcid.org/0000-0003-3293-3158
Article History
Received: 19 July 2020
Accepted: 15 March 2022
First Online: 5 May 2022
Competing interests
: A.R. is a co-founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas Therapeutics and, until 31 July 2020, was a scientific advisory board member of Thermo Fisher Scientific, Syros Pharmaceuticals, Asimov and Neogene Therapeutics. From 1 August 2020, A.R. is an employee of Genentech, a member of the Roche group, and has equity in Roche. The remaining authors declare no competing interests.